Annual Retained Earnings
$10.14 B
+$3.62 B+55.49%
31 December 2023
Summary:
Vertex Pharmaceuticals Incorporated annual retained earnings is currently $10.14 billion, with the most recent change of +$3.62 billion (+55.49%) on 31 December 2023. During the last 3 years, it has risen by +$9.28 billion (+1081.13%). VRTX annual retained earnings is now at all-time high.VRTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
$8.69 B
+$1.05 B+13.67%
30 September 2024
Summary:
Vertex Pharmaceuticals Incorporated quarterly retained earnings is currently $8.69 billion, with the most recent change of +$1.05 billion (+13.67%) on 30 September 2024. Over the past year, it has dropped by -$479.80 million (-5.23%). VRTX quarterly retained earnings is now -22.67% below its all-time high of $11.24 billion, reached on 31 March 2024.VRTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRTX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.5% | -5.2% |
| 3 y3 years | +1081.1% | +257.7% |
| 5 y5 years | +439.3% | +456.9% |
VRTX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1081.1% | -22.7% | +257.7% |
| 5 y | 5 years | at high | +439.3% | -22.7% | +456.9% |
| alltime | all time | at high | +288.7% | -22.7% | +260.8% |
Vertex Pharmaceuticals Incorporated Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.69 B(+13.7%) |
| June 2024 | - | $7.65 B(-32.0%) |
| Mar 2024 | - | $11.24 B(+10.8%) |
| Dec 2023 | $10.14 B(+55.5%) | $10.14 B(+10.6%) |
| Sept 2023 | - | $9.17 B(+12.7%) |
| June 2023 | - | $8.14 B(+12.7%) |
| Mar 2023 | - | $7.22 B(+10.7%) |
| Dec 2022 | $6.52 B(+103.8%) | $6.52 B(+14.4%) |
| Sept 2022 | - | $5.70 B(+19.5%) |
| June 2022 | - | $4.77 B(+20.5%) |
| Mar 2022 | - | $3.96 B(+23.8%) |
| Dec 2021 | $3.20 B(+272.7%) | $3.20 B(+31.7%) |
| Sept 2021 | - | $2.43 B(+54.0%) |
| June 2021 | - | $1.58 B(+4.4%) |
| Mar 2021 | - | $1.51 B(+76.1%) |
| Dec 2020 | $858.70 M(-146.3%) | $858.70 M(+237.4%) |
| Sept 2020 | - | $254.48 M(-161.6%) |
| June 2020 | - | -$412.95 M(-67.0%) |
| Mar 2020 | - | -$1.25 B(-32.5%) |
| Dec 2019 | -$1.85 B(-38.0%) | -$1.85 B(-23.9%) |
| Sept 2019 | - | -$2.44 B(-2.3%) |
| June 2019 | - | -$2.49 B(-9.7%) |
| Mar 2019 | - | -$2.76 B(-7.6%) |
| Dec 2018 | -$2.99 B(-41.6%) | -$2.99 B(-34.2%) |
| Sept 2018 | - | -$4.54 B(-2.8%) |
| June 2018 | - | -$4.67 B(-4.3%) |
| Mar 2018 | - | -$4.88 B(-4.8%) |
| Dec 2017 | -$5.12 B(-4.7%) | -$5.12 B(-1.9%) |
| Sept 2017 | - | -$5.22 B(+2.0%) |
| June 2017 | - | -$5.12 B(-0.4%) |
| Mar 2017 | - | -$5.14 B(-4.4%) |
| Dec 2016 | -$5.37 B(+2.1%) | -$5.37 B(-0.6%) |
| Sept 2016 | - | -$5.41 B(+0.7%) |
| June 2016 | - | -$5.37 B(+1.2%) |
| Mar 2016 | - | -$5.30 B(+0.8%) |
| Dec 2015 | -$5.26 B(+11.8%) | -$5.26 B(+1.4%) |
| Sept 2015 | - | -$5.19 B(+1.9%) |
| June 2015 | - | -$5.09 B(+3.9%) |
| Mar 2015 | - | -$4.90 B(+4.2%) |
| Dec 2014 | -$4.71 B(+18.6%) | -$4.71 B(+3.9%) |
| Sept 2014 | - | -$4.53 B(+3.9%) |
| June 2014 | - | -$4.36 B(+3.8%) |
| Mar 2014 | - | -$4.20 B(+5.9%) |
| Dec 2013 | -$3.97 B(+12.6%) | -$3.97 B(-1.1%) |
| Sept 2013 | - | -$4.01 B(+3.2%) |
| June 2013 | - | -$3.89 B(+1.5%) |
| Mar 2013 | - | -$3.83 B(+8.7%) |
| Dec 2012 | -$3.52 B(+3.1%) | -$3.52 B(+2.2%) |
| Sept 2012 | - | -$3.45 B(+1.7%) |
| June 2012 | - | -$3.39 B(+2.0%) |
| Mar 2012 | - | -$3.32 B(-2.7%) |
| Dec 2011 | -$3.41 B(-0.9%) | -$3.41 B(-4.4%) |
| Sept 2011 | - | -$3.57 B(-5.8%) |
| June 2011 | - | -$3.79 B(+4.8%) |
| Mar 2011 | - | -$3.62 B(+5.1%) |
| Dec 2010 | -$3.44 B(+28.1%) | -$3.44 B(+5.5%) |
| Sept 2010 | - | -$3.26 B(+6.8%) |
| June 2010 | - | -$3.06 B(+7.0%) |
| Mar 2010 | - | -$2.86 B(+6.1%) |
| Dec 2009 | -$2.69 B(+31.4%) | -$2.69 B(+6.3%) |
| Sept 2009 | - | -$2.53 B(+6.3%) |
| June 2009 | - | -$2.38 B(+7.8%) |
| Mar 2009 | - | -$2.21 B(+7.9%) |
| Dec 2008 | -$2.05 B(+29.0%) | -$2.05 B(+7.5%) |
| Sept 2008 | - | -$1.91 B(+7.3%) |
| June 2008 | - | -$1.78 B(+5.4%) |
| Mar 2008 | - | -$1.68 B(+6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | -$1.59 B(+32.7%) | -$1.59 B(+5.7%) |
| Sept 2007 | - | -$1.50 B(+7.7%) |
| June 2007 | - | -$1.39 B(+9.2%) |
| Mar 2007 | - | -$1.28 B(+6.7%) |
| Dec 2006 | -$1.20 B(+20.9%) | -$1.20 B(+2.3%) |
| Sept 2006 | - | -$1.17 B(+4.6%) |
| June 2006 | - | -$1.12 B(+7.5%) |
| Mar 2006 | - | -$1.04 B(+5.1%) |
| Dec 2005 | -$989.58 M(+25.9%) | -$989.58 M(+4.0%) |
| Sept 2005 | - | -$951.45 M(+9.1%) |
| June 2005 | - | -$871.88 M(+4.9%) |
| Mar 2005 | - | -$830.89 M(+5.7%) |
| Dec 2004 | -$786.17 M(+26.8%) | -$786.17 M(+5.8%) |
| Sept 2004 | - | -$743.40 M(+5.5%) |
| June 2004 | - | -$704.63 M(+6.7%) |
| Mar 2004 | - | -$660.36 M(+6.5%) |
| Dec 2003 | -$619.92 M(+46.5%) | -$619.92 M(+7.1%) |
| Sept 2003 | - | -$578.89 M(+17.5%) |
| June 2003 | - | -$492.47 M(+22.3%) |
| Mar 2003 | - | -$402.54 M(-4.9%) |
| Dec 2002 | -$423.15 M(+34.5%) | -$423.15 M(+8.2%) |
| Sept 2002 | - | -$391.07 M(+9.4%) |
| June 2002 | - | -$357.62 M(+6.2%) |
| Mar 2002 | - | -$336.60 M(+7.0%) |
| Dec 2001 | -$314.53 M(+26.7%) | -$314.53 M(+1.0%) |
| Sept 2001 | - | -$311.27 M(+23.8%) |
| June 2001 | - | -$251.46 M(+5.1%) |
| Mar 2001 | - | -$239.35 M(-3.6%) |
| Dec 2000 | -$248.30 M(+30.1%) | -$248.30 M(+13.3%) |
| Sept 2000 | - | -$219.23 M(+12.8%) |
| June 2000 | - | -$194.37 M(-6.1%) |
| Mar 2000 | - | -$206.99 M(+8.5%) |
| Dec 1999 | -$190.83 M(+27.3%) | -$190.83 M(-0.9%) |
| Sept 1999 | - | -$192.50 M(+8.0%) |
| June 1999 | - | -$178.30 M(+6.5%) |
| Mar 1999 | - | -$167.40 M(+11.7%) |
| Dec 1998 | -$149.90 M(+28.3%) | -$149.90 M(+9.2%) |
| Sept 1998 | - | -$137.30 M(+1.7%) |
| June 1998 | - | -$135.00 M(+7.8%) |
| Mar 1998 | - | -$125.20 M(+7.2%) |
| Dec 1997 | -$116.80 M(+20.5%) | -$116.80 M(+6.2%) |
| Sept 1997 | - | -$110.00 M(+5.7%) |
| June 1997 | - | -$104.10 M(+1.4%) |
| Mar 1997 | - | -$102.70 M(+6.0%) |
| Dec 1996 | -$96.90 M(+70.3%) | -$96.90 M(+4.1%) |
| Sept 1996 | - | -$93.10 M(+7.4%) |
| June 1996 | - | -$86.70 M(+34.6%) |
| Mar 1996 | - | -$64.40 M(+13.2%) |
| Dec 1995 | -$56.90 M(+60.7%) | -$56.90 M(+1.4%) |
| Sept 1995 | - | -$56.10 M(+14.3%) |
| June 1995 | - | -$49.10 M(+22.4%) |
| Mar 1995 | - | -$40.10 M(+13.3%) |
| Dec 1994 | -$35.40 M(+98.9%) | -$35.40 M(+16.1%) |
| Sept 1994 | - | -$30.50 M(+14.7%) |
| June 1994 | - | -$26.60 M(+26.1%) |
| Mar 1994 | - | -$21.10 M(+18.5%) |
| Dec 1993 | -$17.80 M(-10.6%) | -$17.80 M(-33.1%) |
| Sept 1993 | - | -$26.60 M(+11.3%) |
| June 1993 | - | -$23.90 M(+3.0%) |
| Mar 1993 | - | -$23.20 M(+16.6%) |
| Dec 1992 | -$19.90 M(+74.6%) | -$19.90 M(+15.7%) |
| Sept 1992 | - | -$17.20 M(+15.4%) |
| June 1992 | - | -$14.90 M(+14.6%) |
| Mar 1992 | - | -$13.00 M(+14.0%) |
| Dec 1991 | -$11.40 M(+83.9%) | -$11.40 M(+14.0%) |
| Sept 1991 | - | -$10.00 M(+13.6%) |
| June 1991 | - | -$8.80 M(+41.9%) |
| Dec 1990 | -$6.20 M | -$6.20 M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual retained earnings?
- What is the all time high annual retained earnings for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual retained earnings year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly retained earnings?
- What is the all time high quarterly retained earnings for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly retained earnings year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual retained earnings?
The current annual retained earnings of VRTX is $10.14 B
What is the all time high annual retained earnings for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual retained earnings is $10.14 B
What is Vertex Pharmaceuticals Incorporated annual retained earnings year-on-year change?
Over the past year, VRTX annual retained earnings has changed by +$3.62 B (+55.49%)
What is Vertex Pharmaceuticals Incorporated quarterly retained earnings?
The current quarterly retained earnings of VRTX is $8.69 B
What is the all time high quarterly retained earnings for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly retained earnings is $11.24 B
What is Vertex Pharmaceuticals Incorporated quarterly retained earnings year-on-year change?
Over the past year, VRTX quarterly retained earnings has changed by -$479.80 M (-5.23%)